American University in Cairo

AUC Knowledge Fountain
Theses and Dissertations

Student Research

Fall 9-14-2019

Direct conversion of mouse fibroblasts into osteoblasts and
investigating COBRA1 expression responce
Walid Almoafy Alasar
The American University in Cairo

Follow this and additional works at: https://fount.aucegypt.edu/etds

Recommended Citation

APA Citation
Alasar, W. A. (2019).Direct conversion of mouse fibroblasts into osteoblasts and investigating COBRA1
expression responce [Master's Thesis, the American University in Cairo]. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/1440

MLA Citation
Alasar, Walid Almoafy. Direct conversion of mouse fibroblasts into osteoblasts and investigating COBRA1
expression responce. 2019. American University in Cairo, Master's Thesis. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/1440

This Master's Thesis is brought to you for free and open access by the Student Research at AUC Knowledge
Fountain. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of AUC
Knowledge Fountain. For more information, please contact thesisadmin@aucegypt.edu.

THE AMERICAN UNVERSITY IN CAIRO
الجامعة االمريكية بالقاهرة

School of Science and Engineering

Direct Conversion of Mouse Fibroblasts into
Osteoblasts and Investigating COBRA1
Expression Response

A Thesis Submitted to

The Biotechnology Master Program
In partial fulfillment of the requirements for the degree of Master of
Science

By:

Walid Alaasar
Under the supervision of:

Dr. Asma Amleh
Associate Professor, Department of Biology
The American University in Cairo
September/2017

Acknowledgments
I would like to thank Dr. Asma Amleh for her support and patience. I am also
grateful for Dr. Adham Ramadan's support.
Great help was offered to me from my colleagues; Noha Saad, Nancy Hasanein,
Myret Ghabriel, Menna Ghoraba and Menna Alfar. So thank them all so much.
Finally, I would like to express much gratitude to the AUC for providing the grant
that funded this research.

i

Abstract
Fibroblasts are the most common connective tissue cells and are responsible for the
synthesis of extracellular matrix (ECM) and collagen. They are mainly of
mesenchymal stem cells (MSCs) origin. Fibroblasts are fully differentiated cells
although some recent findings reported that fibroblasts possess some potency that
allows them to differentiate into other cells types. They are said to undergo
adipogenic, chondrogenic, hepatogenic, nurogenic and osteogenic differentiation if
grown in the suitable conditions. In the normal physiologic environment, fibroblasts
can also differentiate to epithelial cells, a phenomenon known as the mesenchymal
epithelial transition (MET).
In the current research, we induced L929 mouse fibroblasts to differentiate into
osteoblasts cells using the growth media containing Dexamethazone, Ascorbic acid
and Beta-Glycerol phosphate which are the substances known to promote osteogenic
differentiation. We have increased the concentration of dexamethazone than that used
previously, and investigated the effect of this increase on the time of induction. We
also investigated the levels of Cobra1 (which is an integral member of the negative
elongation (NELF) complex) mRNA in L929 that underwent osteogenic induction
compared to the non-induced ones. We show a successful induction the onset of
which is earlier than previously reported in the literature. Furthermore, to the best our
knowledge our current data, for the first time, suggest a potential role of Cobra1 in
maintaining the plasticity of L929.
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Introduction
Fibroblasts are the most common connective tissue cells and are responsible for the
synthesis of extracellular matrix (ECM) macromolecular structure that provides
physiological support to tissues and organs allowing them to perform their functions.
They are derived from mesenchymal stem cells (MSCs). And Like MSCs, fibroblast
cells appear to possess multi-lineage differentiation capacity, albeit to a lesser extent
(Kasem, Tanom, 2011). . In the presence of inducers of differentiation fibroblast
cells were found to produce adipocytes, chondrocytes, and osteoblasts (Kasem,
Tanom, 2011). By adding osteogenic molecules (Dexamethazone, Ascorbic acid and
B-Glycerol phosphate) in the culture media fibroblast will differentiate into
osteoblasts (Jarosław et al., 2016). Moreover, fibroblast cells are known to
differentiate into epithelial cells; a phenomenon referred to as the mesenchymal
epithelial transition (MET) which is essential for organ architecture during fetal
organogenesis (Dianbo et al., 2011).
The source of different somatic cells for laboratory or clinical uses has been the
pluripotent stem cells either embryonic (with all the concerned ethical debate) or
induced in the laboratory (with all the relevant difficulties, high cost, and low yield).
So using the capacity obtained by certain somatic cells to differentiate into other cell
types may be beneficial.
Valuable information is present regarding how the fibroblasts are induced to
differentiate into osteoblasts (Kasem, Tanom, 2011). This induction was done by
growing fibroblasts in osteogenic media with a certain concentration that resulted in
an extended period of time consumed by the fibroblasts to differentiate into fully
mature and active osteoblasts that can mineralize the matrix (about two weeks).
Changing the concentration of the osteogenic media used may result in earlier
differentiation of the fibroblasts.
It is also unclear whether fibroblasts will attain any degree of potency before
performing such differentiation. Here some questions arise and need to be answered;
-Are fibroblasts passing through a period of time in which the differentiation genes to
any lineage are repressed
-Did the fibroblasts express any marker which its expression suppresses
differentiation genes.
Or what is happening is direct change to other cell type by direct switching on and
switching off certain differentiation genes.
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Chapter (1): Literature review
1.1 Fibroblasts
Fibroblasts are connective tissue cells; they are responsible for synthesis of
extracellular matrix and collagen. Fibroblasts are the principal active cells of
connective tissue. They are large, flat, elongated (spindle-shaped) cells possessing
processes extending out from the ends of the cell body. Fibroblasts produce
tropocollagen, which is the forerunner of collagen, and ground substance.
The extracellular matrix (ECM) is a collection of molecules found between cells and
secreted by them. It differs according to the type of connective tissues, in bone the
extracellular matrix is composed of collagen fibers and mineralized bone tissue, in
loose connective tissue it is composed of reticular fibers and ground substance while
it constitutes the blood plasma. The structure of the extracellular matrix determines
the physical properties of the connective tissues, and acts as a compression buffer
against forces applied in the connective tissues (Thomas and Janine, 2010).
The extracellular matrix provides the structural and biochemical support to the
surrounding cells; it plays an important role in cell division, cell adhesion, cell-to-cell
communications and plays a critical role in wound healing (Lauren et al., 2016).
Fibroblasts are the most common cells in the connective tissue. Fibroblasts and
fibrocytes are two different states of the same cell, the fibroblast is the activated state
and they have different appearance according to state of activation and location. By
secreting extracellular matrix which is composed of ground substance and fibers,
fibroblasts maintain the structural integrity of the connective tissue.
The origin of fibroblasts like other connective tissue cells is the mesenchymal stem
cell (MSC) which is an adult stem cell that can give rise to distinct group of cells
(César et al., 2011). Fibroblasts can arise also from epithelium cells in certain cases
in a phenomenon known as epithelial mesenchymal transition (EMT) (Raghu
and Robert, 2009). In other situation the opposite can occur where fibroblasts may
give rise to epithelial cells, which is known as mesenchymal epithelial transition
(MET) (Dianbo et al., 2011) in certain circumstances as wound healing and tumor
genesis.
2

Fibroblasts have branched cytoplasm, the nucleus has two or more nuclei, and
abundant endoplasmic reticulum in active fibroblasts. Fibroblasts can migrate slowly
as individual cell, and when cover large space, they are disjointed and scattered, but
when crowded they are locally arranged in parallel clusters. In its active state as in
growing individual and in wound healing the fibroblasts are dividing and secreting
extra cellular matrix composed of collagen, glycosamino glycans, reticular and elastic
fibers, glycoprotein found in the extracellular matrix and cytokines (Lauren et al.,
2015).
Fibroblasts play important role in the initiation of inflammatory process against an
invading microorganism (TA Wynn, 2008). Certain receptors in fibroblast surface
induce chemokines synthesis, the immune cells will respond to chemokines to clear
the invasive microorganisms. The fibroblast receptors also regulate blood formation
and give rise for the immune cells to regulate fibroblasts.
Certain fibroblasts as the tumor associated host fibroblasts (TAF) play a critical role
in immune regulation of tumors through the extracellular matrix components and
modulators (Michelle et al., 2017). The mouse embryonic fibroblasts (MEF) are used
as feeder cells in stem cells researches.
1.2 Osteoblasts
Osteoblasts is another type of connective tissue cells and as fibroblasts they arise from
mesenchymal stem cells (Pittenger et al., 1999). They are responsible for bone
formation. Osteoblasts are cells with single nuclei and function as a group of
connected cells. The unit of bone is called the osteon and consists of a group of
osteoblasts and the bone formed by them.
Osteoblasts synthesize mainly dense collagen type1 which constitutes about 90% of
the bone organic matrix, it also secret specialized proteins such as Osteocalcin and
Osteopontin in a much less quantity (Bart, 2008). Oseoblasts then mineralize the
organic matrix by depositing calcium and phosphorous in forms of hydroxyapatite, as
the main component, as well as tricalcium phosphate and traces of many other salts.
This mineralized matrix (bone) gives support to the body structure and acts as a
mineral reservoir
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Bone tissue is in constant state of flux, that means that it is a dynamic tissue that
changes in shape and density in processes called modeling and remodeling (Seeman,
2009) in which constant alternative bone formation and bone resorption occur. The
older bone, of high density and heavy weight relatively, which becomes brittle will be
resorbed to give rise to deposition of newly formed bone with accepted density and
hardness. If the resorption and deposition occur in the same site this is called
remodeling which occurs in jaws bone, ribs and flat bones of the skull, on the other
hand, modeling occurs in long bone of the skeleton where the resorption occurs from
inside the bone (marrow side) and the deposition of newly formed bone occurs
laterally on the external surface of bone.
Two types of bone cells are responsible for modeling and remodeling of bone, which
are osteoblasts responsible for bone formation and osteoclasts responsible for bone
resorption. The imbalance between osteoblastic and osteoclastic activities result in
certain diseases as osteoporosis where there is increased activities of osteoclasts.
The osteoblasts are found in the periostium outside the bone surface, and in endostium
layer at the inner surface of cortical lamellar bone and as a single layer of osteoblasts
lining the mineralized tissue in trabicular bone and facing the osteoid bone tissue,
which is the organic non-mineralized substances.
The outer osteoblastic layer is a layer of inactive flattened osteoblastic cells,. Another
form of inactive osteoblasts is found where the osteoblasts are buried into the bone
matrix to become the osteocytes, which are vital but inactive and remain connected to
each others and to other osteoblasts through cell processes.
The bone formation and maturation (the osteogenesis) is done by one of two different
processes, the endochondral ossification and the intramembranous ossification
(E.J.Mackie et al., 2008). In endochondral ossification, bone is formed from
cartilage, where resorption of cartilage is followed by bone formation, this
ossification pattern is unusual. Whereas in the intamembranous ossification, there is
direct ossification of the mesenchyme.
During osteoblastic differentiation, the osteoproginitor cells express the regulatory,
transcription factor Cbfa1/Runx2 and Sp7 transcription factor (Tong , and Eng,
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2017) . The osteochondro progenitor cells differentiate under influence of growth
factors. (Arkady et al., 2016)
Certain signaling molecules regulate osteogenesis, BMP (bone morphogenetic
protein) is a key growth factor in endochondral skeletal differentiation; also, it
regulates early skeletal patterning (Maureen et al., 2013). Transforming growth
factor beta (TGF b) is a part of super family of proteins, which includes the bone
morphogenetic proteins that have common signaling elements. Transforming growth
factor beta is important in cartilage differentiation, which proceed bone formation in
endochondral ossification. Another family of transforming growth factors determines
where skeletal element occurs in relation to skin.
Parathyroid hormone plays an important role in osteoblastic regulation. Parathyroid
hormone (PTH) increases the osteoblastic activities, while in high concentration it
leads to degradation of bone matrix (Lombardi et al., 2011).
Estrogen and Glucocorticoids are important for reproduction and energy metabolism
regulation of bone cells, while the Adrenocorticotropic hormone (ACTH), in low
concentration increases the activities of osteoblasts, while its increase leads to bone
resorption. Its lack leads to osteoscelerotic bone.
Individual osteoblasts are connected to each others by two types of connection, tight
junction and gap junction (Bart., 2008).
The bone organic matter is composed mainly of collagen type 1 protein, which is
responsible for bone tensile strength. The osteoblasts secret collagen in two
orientation and change the orientation of the collagen every few micrometers,
osteoblasts deposit layer of collagen parallel to bone orientation alternative with layer
perpendicular to bone orientation. The deficiency of collagen type 1 is inherited
disorder of bone called osteogenesis imperfecta. Small amounts of Osteocalcin and
Osteopontin bone proteins is deposited by osteoblasts to connect the organic and
mineral contents of bone together. The Osteocalcin protein is not expressed except in
bone tissue so it is a marker for bone matrix synthesis.
The bone mineralization occurs when calcium and phosphorous are deposited into the
bone matrix (Bart, 2008), and due to the tight junction between the osteoblastic cells,
the calcium and phosphorous cannot move in or out the bony compartment. The
5

calcium is transported across the osteoblasts by facilitated transport which means
passive transport which does not pump calcium against gradient. The phosphorous in
contrast is actively produced in form of phosphorous containing compounds like ATP.
The osteoblbasts secret also phosphatases to cleave phosphorous to be free for
mineralization formation.
The alkaline phosphatase protein is membrane anchored protein present at the surface
of osteoblasts and expressed in large amount at the apical secretory face of active
osteoblasts and considered as a characteristic marker for bone formation.
hydroxyapatite is formed of calcium, phosphate and water at slightly alkaline PH as
following:
6 HPO4 + 2H2O + 10Ca  Ca10(PO4)6(OH)2 + 8H
So, lowering the PH stops further precipitation. In case of cartilage, it presents no
barrier for diffusion so the acid diffuse away, while in closed compartments the Na/H
exchange removes the acid. In bone removal, reverse transport mechanism causes
acid to be delivered to the mineralized matrix to drive hydroxyapatite into solution.
The osteocytes have an important feedback mechanism as they secret sclerostin
protein when the osteon reaches a limiting size (Mitchell et al., 2014), this protein
inhibits osteoblastic activity and inactivate bone synthesis. The osteoblasts have
spherical and large nucleus with substantial presence of rough endoplasmic reticulum.
In active osteoblasts, there is prominent Golgi apparatus, which appears as clear zone
adjacent to nucleus.
1.2.1 Osteoblastic differentiation:
The bone marrow mesenchymal stem cells (MSCs) are multipotent stem cells and
they are the origin of osteoblasts (Jess et al., 2008). They possess a highly
proliferative capacity and can give rise to unipotent progenitor cells of many types as
chondroproginitor cells, osteoproginitor cells and adepocyte progenitor cells. In other
tissue types, the mesenchymal stem cells can give rise to other cell types such as
myoblasts, hematocytes and neural tissues.
The osteoblasts differentiation passes through different stages (Arkady et al., 2016).
The first is the inductive and proliferative stage in which the mesenchymal stem cells
are committed to form osteoproginitor cells that divide, migrate and end by the
6

formation of primitive osteoblasts. The second stage is the differentiation of
osteoblasts and synthesis of extracellular organic matrix and full maturation of
osteoblasts. The third stage is the mineralization of the organic matrix by the fully
mature osteoblasts.
During these stages of differentiation from the mesenchymal stem cells to mature
osteoblasts the cells are influenced by different factors, and each stage of
differentiation is characterized by the expression of definite osteoblatic markers. The
factors that influence the osteoblastic differentiation include: signaling protein and
molecules, transcription regulation factors, growth factors and hormones. The
following is a detailed description of these factors and their rules in osteogenesis:
1.2.2 Factors influencing osteogenesis
Runx2:
Runx2 is the master transcription factor that regulates osteogenesis. It acts through the
induction, differentiation and maturation of osteoblasts (Jess and Paul, 2008). Many
transcription factors and signaling pathways that influence osteogenesis do so by
affecting Runx2 expression and activities (Banerjee et al., 1997). The expression of
Runx2 is poorly correlated to the expression of its target gene as the Runx2 protein
passes through post translation modifications like phosphorylation, acetylation and
ubiquetenation which facilitate degradation of Runx2 by proteosomes, (Bellido et
al., 2003) alter Runx2 activities or its cellular location.
Runx2 regulates the expression of many osteoblast genes (Komori et al., 1997), in
addition to its DNA binding motifs, Runx2 contains multiple domains for transcription
co-activators or co-repressors (Jess and Paul, 2008).
Histone acetyl transferases such as P300, CBP, PCAF, MOZ and MORF are coactivator for Runx2 (Hecht et al., 2000). They add acetyl group to lysine residues of
histone and non-histone target proteins, and they alter protein-protein interaction and
protein stability (Pelletier et al., 2002). In case of neucleosomal histone acetylation,
this refers to opened chromatin structure which leads to more transcription activity of
the target gene (Sierra et al., 2003). Opposite action is done by histone deacetylases
(HDACs), (Cho et al., 2005) which leads to deacetylization of histone that results in
more condensed chromatin structure and inhibits transcription of the target gene
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(Geneviève et al., 2012). Inhibition of deacetylation at Runx2 repression domain
increases Runx2 activities, this inhibition of dsacetylsaes could be done by small
molecule inhibitors or RNAi suppression thus enhances osteogenesis. On the other
hand HDACs are co-repressors of Runx2 as they bind Runx2 and inhibit its activity
(Jensen et al., 2007).
Multiple HDACs are co-repressors of Runx2 as HDAC3,4,5,6and 7, HDAC6
represses Runx2 through its enzymatic activity, so inhibition of HDAC6 enzymatic
activity can save Runx2 from suppression effect of HDAC6 (Westendorf et al.,
2002) while for HDAC7 (Jensen et al., 2007) this is not the case as it does not
employ its enzymatic activity to repress Runx2, the mechanism of HDAC7 repression
of Runx2 is not clearly understood, however HDAC7 repression effect could be
inhibited by BMP2 (bone morphogenetic protein 2) (Jeon et al., 2006) which activate
protein kinase D1 (PK D1) that phosphorylate HDAC7 and leads to transient export
of HDAC7 from nucleus so freeing Runx2 from repression by HDAC7. Protein
kinases can induce HDAC4, HDAC5 and HDAC7 to be exported from the nucleus
even they exhibit different response to BMP2 stimulation (Vega et al., 2004).
HDACs proteins usually form large multi component repressive complex containing
in addition to HDACs cofactors of HDACs such as NCor, SMRT and Sin3a
(Geneviève et al., 2012). The Runx2 target genes expression is repressed by HDACs
through different mechanisms and in response to various osteogenic signals including
BMP2 and PTH (parathyroid hormone). At BSP (bone sialo protein) promoter,
deacetylation of histone and subsequent repression of BSP transcription occurs as a
result of recruitment of HDAC3 by Runx2 at promoter site (Lamour et al., 2007).
BMP2 stimulates Runx2 acetylation through SMAD dependent mechanism, SMADs
are transcription factors that transduce extracellular TGF beta super family ligand
signaling from cell membrane. Runx2 acetylation protect Runx2 from Smurf1
catalyzed proteolysis (Zhao et al., 2003). Smurf1 and Schnurri-WWP1 are ubiquitin
ligases that leads to proteolysis of Runx2, Runx2 acetylation by P300 is counter acted
by HDAC4 and HDAC5 which remove the acetyl group from Runx2 and thus brings
Runx2 to ubiquitin mediated proteolysis. BMP2 also stimulates the expression of
estrogen related receptor which competes with P300 for Runx2 thus preventing
acetylation of Runx2 and inhibiting BMP2 induced osteogenesis. (Abe et al., 2000).
8

Parathyroid hormone (PTH):
Parathyroid hormone (PTH) is another regulator of osteogenesis (Lombardi et al.,
2011) which stimulates Runx2 interaction with acetyl transferases and induces Runx2
activity. Stimulation of osteoblasts by PTH leads to protein kinase A (PK A)
dependent binding of P300 with Runx2 on the MMP13 (matrix metalooprotein 13)
promoter resulting in histone acetylation and increased MMP13 gene expression.
(Bomah et al., 2009). PTH also regulates Runx2 activity via different mechanisms
such as phosphorylation and enhancing interaction with AP 1 transcription factor
(Ahlström and Lamberg., 1997). On the other hand, PTH decreases Runx2 stability
by stimulating ubiquintin mediated proteolysis limiting PTH stimulation of
osteoblasts genes.
Osterix:
Osterix (Osx or SP7) is a zinc finger transcription factor expressed in osteoblast and
as Runx2 is required for bone formation (Jess and Paul, 2008). It acts through the
mineralization of bone, and it acts mainly in osteoblasts so the Osx-null mice lack
intra membranous bone mineralization. Osx is down regulated by Runx2 which have
a definite binding element on Osx gene promoter. Osterix activate collagen 1A1
promoter and this activation is enhanced by binding NFATc1 to Osx, the binding
which is disrupted by calcineurin. Osterix also inhibit canonical Wnt signaling by
inhibiting DNA binding to TCFs transcription factors.
ATF4 (activating transcription factor 4):
ATF4 has an important role in osteoblast formation. It is considered as a substrate for
RSK2 which is serine/therotonin kinase essential for osteoblastogenesis, RSK2
mutation result in various skeletal abnormalities. ATF4 combined with Runx2
increases the transcription of osteocalcin and this is found to be activated by PTH
signaling. Deficiency in ATF4 results in decreased bone formation. ATF4 also
regulates energy metabolism in osteoblasts through decreased insulin production and
responsiveness via altered osteocalcin and leptin endocrine signaling pathways (Lee
et al., 2007).
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SMADs:
SMADs are transcription factors interact directly with DNA and with other
transcription factors as Runx2 to induce bone formation (Eric et al., 2010). The
Runx2 domain for SMAD interaction has been identified and has been found to be
continuous with the nuclear matrix target sequence. By SMAD activation of Runx2,
the MSCs are induced to committee to the osteoblastic lineage through the induction
of Runx2 transcription. SMADs are activated through signaling by BMP and TGF beta
family (transforming growth factors beta), they cause phosphorylation and nuclear
translocation of receptor activated SMADs (rSMADs)
SMADs are inactivated by Smurf-directed ubiquitination which leads to proteolysis of
SMADs. An interesting feedback loop is present among Runx2, SMADs and BMP that
is BMP acts on Runx2 to induce formation of SMAD6 which is inhibitory for BMP
activity and also leads to Smurf-directed ubiquitination of Runx2 which leads to
Runx2 proteolysis, so via the two mechanisms SMAD6 leads to decreased bone
formation to prevent excess osteogenesis.
NFATc1/Calcinurin:
NFATc1 is a transcription factor which is highly phosphorylated and located in
cytoplasm, it is dephosphorylated and imported to the nucleus by the effect of
Calcinurin (Hogan et al., 2003) which is a phosphatase induced by intra cellular
calcium signaling, import of NFATc1 to the nucleus leads to transcription of its target
genes (Choo et al., 2009) . In osteoclasts, NFATc1 increases the osteoclastic activities
and bone resorption, while in osteoblasts it increases bone formation through
activation of Osterix transcription. Over expression of NFATc1 leads to decreased
bone formation and maturation, it inhibits TCF/LEF transcription activity leading to
reduced osteocalcin transcription via recruitment of HDAC3 to osteocalcin gene
which ends in more condensed chromatin structure and decrease transcription.
Twist:
Twist is basic helix-loop-helix transcription factor which antagonize
osteoblastogenesis, (Bialek et al., 2004). It binds to DNA at Runx2 domain thus
preventing Runx2 from binding DNA, which results in inhibiting the transcription of
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many osteogenesis genes. Twist also inhibits BMP/SMAD responsive transcription by
forming a complex with SMAD4 and HDAC1 (el Ghouzzi et al., 1997).
Activator protein (AP1):
AP-1 is a transcription factor composed of Fos related factors (c-Fos, Fra1, Fra2 and
FosB) and Jun protein (c-Jun, Jun B and Jun D). Multiple Fos and Jun proteins are
highly expressed in proliferating osteoproginitor cells (Grigoriadis et al., 1994) and
decreases after that to the extent that only Fra2 and JunD are the AP-1 proteins found
in mature osteoblasts (McCabe et al., 1996). At certain promoters AP-1 interact with
other transcription factors such as vitamin D receptor and Runx2 to induce
transcription of those genes (Grigoriadis et al., 1993), such genes like osteocalcin,
collagenase-3, MMP 13, bone sialoprotein and alkaline phosphatase.
Tcf7/Lef1 transcription factors:
Tcf (T-cell factor) and Lef (lymphoid enhancer factor), these protein are nuclear
effectors of canonical Wnt signaling (Ken and Marian, 2012). Activation of
canonical Wnt signal transduction stabilize beta-catenin which translocates into
neucleus (Birnbaumer., 1990) and associate with Tcf7/Lef1 transcription factors, this
association replaces HDACs and increases transcription of osteoblasts genes. Over
expression of Tcf7/Lef1 co-activators enhances expression of osreoprotegerin (OPG)
which inhibits osteoclastogenesis and decreases bone resorption (Glass et al., 2005),
while over expression of Lef1 inhibits late state of osteoblastogenesis.
Zinc finger proteins:
Two maim families of zinc finger transcription factors are present (Glimcher et al.,
2007), the Krupple-like factors (KLFs), and specificity proteins (SPs). They interact
with other transcription factors at promoters of target osteoblastic genes to increase
transcription.
Micro RNAs (miRs):
These short non coding RNA ranging from 18-25 nucleotide binds to mRNA and
leads to its degradation or prevents its translation, many of these miRs inhibits
osteogenesis by repression of many osteoblast genes (Bantounas et al., 2004).
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1.3 Osteogenic media:
The standard protocol for osteogenic differentiation of multipotent stem cells (bone
marrow mesenchymal stem cells) is treatment of confluent mono layer of cells with a
cocktail of Dexamefhazone (Dex), Ascorbic acid (Asc) and Beta Glycerol phosphate
(Beta Gly). These substances result in intracellular signaling cascades which lead to
osteogenic differentiation (Kasem and Tanom, 2011).
Dexamethazone:
Dexamethzone induce Runx2 expression by FHL2/B-catenin mediated transcription
activation, FHL2 protein activates Wnt/B-catenin signaling dependant Runx2
expression. Dex binds to glucocorticoid response element on the FHL2 promotor
leading to increased FHL2 expression. The Wnt3a (an activator of canonical Wnt
signaling) leads to binding of FHL2 to Beta-catenin which leads to transport of Betacatenin into the nucleus where it bind to TCF/LEF1 and leads to transcription of
Runx2. In addition to Runx2 expression, collagen type1 (Col1) is also up regulated
(Runx2 deficiency has no effect of Col1 expression (Hamidouche et al., 2008).
Dex signaling leads to transcription of TAZ which is a transcription activator that
recruits the transcription machinery component for Runx2 expression while in the
same time TAZ represses transcription factors required for adipogenic differentiation.
TAZ is crucial factor in osteogenic differentiation.
For Runx2 activation and its binding to TAZ, it needs to be dephosphorylated. This
dephosphorylation is done by the action of mitogen-activated protein kinase
dephosphatase (MKP 1) whose expression is induced by Dex signaling. MKP1
dephosphorylate the serine resedue 125 of Runx2. After Runx2 combination with TAZ,
it needs to be phosphorylatd again on other serine resedues other than the serine125,
this is done through cascade of events leading to Runx2 phosphorylation without the
need of Dex, however Dex increases the phosphorylation of Runx2 through its up
regulation of Col1 whose secretion and the subsequent extracellular presence together
with extracellular phosphorous can positively affect the signaling that leads to Runx2
phosphorylation (Hamidouche et al., 2008).
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Ascorbic acid:
Ascorbic acid induces osteogenic differentiation by increasing Col1 secretion
(Langenbach , Handschel, 2013), Asc is considered as co-factor for enzyme that
hydroxylate proline and lysine in pro-collagin, (Chatterjee., 1973) without this
hydroxylation, the collagen chain cannot attain the helical structure required for
collagen secretion. So the main function of Asc is to facilitate collagen 1 secretion to
the extra cellular matrix (Chojkier et al., 1989). For osteoblasts to differentiate it
should be in contact with collagen1 (Kuivaniemi et al., 1991) containing extra
cellular matrix, osteoblasts communicate with the extracellular matrix through
binding of collagen1 to alph2 beta1 integrin, this binding activates the MAPK
signaling and related pathway which ends in phosphorylation of Runx2 and
expression of osteoblasts genes.
Beta Glycerol phosphate:
Beta Glycerol phosphate is considered as a source of phosphorous for bone minerals
(Langenbach and Handschel., 2013) and also for phosphorylation of extracellular
related kinase (ERK). The inorganic phosphates inter the cell and activate ERK
signaling pathway, this activation is biphasic, first phosphorylation of ERK is
followed after few hours by second phosphorylaion. ERK is not active unless the
second phosphorylation occurs. Activation of ERK pathway leads to phosphorylation
of Runx2 after its combination with TAZ and increase expression of osteoblastic
genes, ERK pathway also induce the transcription of Osteopontin bone protein and
the phosphate related expression of BMP2 which enhances osteogenesis. The
inorganic phosphate regulate BMP2 expression via cyclic AMP/protein kinase A
pathway, which is independent of ERK phosphorylation pathway (Langenbach
, Handschel, 2013).
1.4 Fibroblastic differentiation into osteoblasts:
Using the differentiation media containing cocktail of osteogenic substances
(Dexamethazone, Ascorbic acid and Beta Glycerol phosphate) not only the stem cells
whatever their potency capacity are able to differentiate into fully mature and active
osteoblasts (Jarosław et al., 2016).,but also fully differentiated somatic fibroblasts
are able to differentiate into osteoblasts (Kasem, Tanom, 2011).
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Fibroblasts have the capacity to differentiate into different types of cells using the
suitable differentiation media, this differentiation capacity differs according to the
source of fibroblasts; the species which the cells were driven from and the tissues
origin that cells have originated from. So beside fibroblastic differentiation into
osteoblasts, fibroblasts are able to undergo adipogenic, chondrogenic, neurogenic and
hepatogenic differentiation (de Crombrugghe et al., 2000).
Valuable information are present regarding how the osteogenic substances can induce
osteogenic differentiation to the fibroblasts (Kasem, Tanom, 2011), but this
differentiation consumed a long time which is considered as a limitation of the
induction mechanism. It is also unclear whether fibroblasts will attain any degree of
potency before performing such differentiation, that means: are fibroblasts passing
through a period of time in which the differentiation genes to any lineage are
repressed and the fibroblasts possessed any potency characters which prevent
differentiation or expressed any marker which its expression suppresses
differentiation genes, or what is happening is direct change to other cell type by direct
switching on and switching off certain differentiation genes without passing through
any degree of potency. The potency of cells are achieved through two different
mechanisms, first of them is the maintenance of potency characters and the second
mechanism is differentiation prevention.
1.5 Cobra1:
Cobra1 is the B subunit of NELF (negative elongation factor) and is known as NELFB. It is one of four subunits that constitute this protein, it was considered as co-factor
of BRCA1 but it is found to regulate genes which are regulated by BRCA1 in absence
of BRCA1 (Amleh et al., 2009).
Cobra1 acts interdependently with NELF component to repress the transcription of
genes responsible for cellular differentiation through pausing RNA polymerase and
stopping the elongation of the transcript.
Cobra1 in pluripotent cells is maintaining pluripotency through prevention of
differentiation (Jarosław and Maciej, 2016), it does not repress the transcription of
master genes responsible for pluripotency such as Oct4, Nanog and Sox2, but mainly
regulate differentiation genes although it represses Tcf3 transcription factor that
14

occupies areas of promoters of the master pluripotency regulators, so plays a role in
maintaining pluripotency, however the pluripotency master genes can keep
pluripotency in absence of Cobra1 which means that the main function of Cobra1 is
the prevention of differentiation rather than directly affecting the master regulators of
pluripotency.
Cobra1 deficiency in multi potent stem cells, unipotent progenitor cells and somatic
cells may result in tumor formation, and the cells that lack Cobra1 exhibit high
tendency of differentiation (Amleh et al., 2009).
Cobra1 null embryonic stem cells can not develop to an embryo and experience
lethality although the presence of master pluripotency proteins, and exhibit premature
differentiation.
Cobra1 acts mainly through pausing transcription of Lef1 so inhibits Lef1/Tcfmediated Wnt/Beta-catenin signaling pathway that is important pathway in
transcription of many differentiation genes (Ken and Marian, 2012).
So, Cobra1 prevents differentiation of ESCs and inhibits further differentiation
machinery in somatic cells, and down regulation of Cobra1 in somatic cells may
permit the differentiation machinery of the cells to resume according to the induction
mechanism.
1.6 Collagen1
Collagen type I is the most abundant form of collagen found in bone. It is synthesized
by osteoblasts during bone formation and considered as the major component of the
bone organic matrix. It is considered as a marker of bone formation (Arkady et al.,
2016).
1.7 Osteocalcin
Osteocalcin is a hydroxyapatite-binding protein exclusively synthesised by osteoblast,
odontoblasts and hypertrophic chondrocytes. One of the major function of
Osteocalcin is being responsible for the calcium binding. Osteocalcin can also interact
with other proteins, including cell surface receptors. These functions predispose
Osteocalcin as a molecule active in the organization of the extracellular matrix.
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Study objectives
Regulation of certain genes transcription can induce a change in the cell type when
these genes are responsible for differentiation into another fate of the cells. The
somatic mouse fibroblasts L929 could be differentiated into mature mouse osteoblasts
which possess all features of bone forming cells, including the production of
osteogenic factors such as Collagen1 and Osteocalcin, (Delmas et al., 1986) and bone
minerals. These changes in the cells could be induced using osteogenic differentiation
media containing Dexamethazone, Ascorbic acid and Beta Glycerol phosphate
(Kasem, Tanom, 2011)., Before and after osteogenic induction, the cells could be
examined for the levels of Cobra1 expression to determine if it plays a role in
osteoblastic differentiation, or whether the osteoblastic differentiation mechanism
affects Cobra1 regulation.
The aim of our study is a direct conversion of mouse fibroblasts into osteoblasts using
osteogenic differentiation media, and further to analyze the levels of osteogenic
differentiation factors (Runx2, Collagen1, and Osteocalcin) and a known pluripotent
related gene (Cobra1).
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Chapter (2): Materials and Methods
Experimental design
Mouse fibroblasts L929 were used for this analysis, study cells were incubated with
osteogenic differentiation media containing Dexamethazone, Ascorbic acid and Beta
Glycerol phosphate for 21 days during which the media were changed every 3 days,
Alizarin red stain was applied to monitor the deposition of calcium in the induced and
un-induced L929 cells after 2 and 3 weeks from the onset of induction. The same
timetable has been followed by taking aliquots of control and study cells and
processing them for RNA extraction followed by cDNA synthesis and PCR
amplification using primers for specific osteoblasts genes (Runx2, Osteocalcin and
Collagen1) ( Ericet al., 2010), Cobra1 gene primers and primers of B-actin as a
control. The products of RT-PCR were run on a gel, and transcription analysis was
done.
2-1 cell culture
Mouse fibroblasts L929 cell line was used in this study, the cells in passage 7 were
saved frozen in liquid nitrogen at cell culture lab (Biology department, American
university in Cairo).
Culture media (non osteogenic normal media)
The culture media was composed of; DMEM (Dulbecco's Modified Eagle Medium)
(Lonsa, USA) supplemented with 10% FBS (Fetal bovine serum) (Lonsa, USA) and
5% Penicillin-streptomycin antibiotic (Lonsa, USA).
Differentiation media (osteogenic media)
It was composed of normal culture media supplemented with Dexamethazone 0.7 µM
(Sigma Aldrich) (in previous researches, the concentration used was 1 µM), BGlycerol phosphate 10 mM (Sigma Aldrich) and Ascorbic acid 0.2 mM (Sigma
Aldrich). All the media were sterile filtered. Before the beginning of the experiments,
the L929 fibroblasts were cultured in normal non osteogenic media, incubated at 37°C
in humidified air mixed with 5% Co2 and passed through passage 8 and passage 9.
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At the beginning of the experiment, the cells were seeded in 6 well plates at density of
12500 cell per well (Kasem, Tanom, 2011), included in 3mL media in each well. The
control cells were cultured in normal non osteogenic-media, while the rest of cells
were cultured in differentiation osteogenic media, aliquot was taken from the
fibroblasts in normal media at the beginning of the experiments to be used for RTPCR, and photos were taken to the cells under inverted microscope. All the cells were
incubated at 37°C in humidified air containing 5% Co2.
The media were changed every three days and half, and photos for cells in different
media were taken immediately before every media change. After two weeks and three
weeks from the beginning of the induction (at day 14 and day 21), aliquots were taken
from the control cells and the cells cultured with differentiation media for RT-PCR.
The cells were stained using 2% Alizarin red S solution (Biostain ready reagents ltd.,
United Kingdom) (Kasem, Tanom, 2011), and photos were taken after staining using
inverted microscope.
2-2 Alizarin red S staining
After 14 days and 21 days, the cells were fixed using 4% Paraformaldeyde (Minsing
et al., 2011), washed and stained using Alizarin red S solution (Biostain ready reagent
ltd., United Kingdom), later photos were taken using inverted microscope.
2-3 RNA extraction and quantification
RNA was extracted from cells using Trizol reagent (Invitrogen, USA) as
recommended in the manufacturer protocol. The extracted RNA pellet was dissolved
in 20µl DEPC (diethylpyrocarbonate) treated water. The resultant RNA solution was
further diluted in DEPC in ratio 1:50 (2 µl of RNA solution and 198 µl DEPC) for
quantification of RNA. The RNA samples were quantified by measuring the
absorption at 260nm (A260nm) using spectrophotometer (Shimadzu, Japan) and the
concentration of each RNA sample was calculated. The purity of the RNA samples
was detected by calculating the ratio of A260nm and A280nm and data were
recorded.
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2-4 cDNA synthesis using reverse transcriptase enzyme
Complementary DNA (cDNA) synthesis was done for each RNA sample using
RevertAidTM First Strand cDNA Synthesis Kit (Thermo Scientific, USA) from 1µg of
the extracted RNA according to the manufacturer protocol. This was done using
random primers, reverse transcriptase, dNTPs, RNase inhibitor, buffer and nuclease
free water to the RNA samples. The cDNA synthesis was run using PCR machine
according to manufacturer instructions.
2-5 Polymerase Chain Reaction (PCR)
RT-PCR (Reverse Transcription Polymerase Chain Reaction) was carried out for all
the synthesized cDNA samples. Specific primers were used to test the presence of
mRNA for the target genes. The primers used were: Runx2, Collagen1, Osteocalcin,
Cobra1 and Brta-actin (House keeping gene) as an internal control. The sequences of
the used primers and the amplicon sizes are mentioned in table (1), while the locations
of the primers in respect to the exons are listed in table (2). The PCR reaction was
carried out for each tested gene using a mixture consisting of 1 µl cDNA template, 5
µl 10X Dream Taq Green Buffer containing dNTP mix (Thermo Scientific), 0.25 µl
Dream Taq DNA Polymerase (Thermo Scientific), 0.75 µl of each forward and
reverse primers and 17.25 µl nuclease free water to reach final volume of 25µl. The
PCR conditions were optimized for each gene and mentioned in table (3).
The amplified PCR product was run on 2% agarose gel electrophoresis and visualized
using Gel Doc EZ System (Bio-Rad, USA). The samples loaded onto gel were as
following: 100 bp ladder, PCR product free of cDNA template but contained Reverse
Transcriptase during cDNA synthesis, water free of any impurities, PCR products of
the cDNA synthesized from RNA extracted from fibroblasts which were cultured
without differentiation osteogeic media at day 1, day 14 and day 21, in addition to
their control (samples containing no Reverse Transcriptase during cDNA synthsis), in
addition to PCR products of the cDNA synthesized from RNA extracted from
fibroblasts which underwent culturing in differentiation osteogenic media at day 14
and day 21, in addition to their control that had no Reverse Transcriptase during
cDNA synthesis.
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2-6 ImageJ software and Statistical analysis
The intensities of the bands in PCR products in the reactions concerning Runx2,
Collagen1, Osteocalcin and COBRA1 were measured and normalized to the Betaactin, which was used as an internal control. The presented data for Runx2, Collagen1
and Osteocalcin were averages +/- standard deviation (SD), the mean SD was used to
produce the error bar for each gene result and the P-value for significance was
calculated. A P-value less than 0.05 was considered significant (*P < 0.05; **P <
0.01; ***P < 0.001).
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Table 1: Sequences of primers used in the Reverse Transcription PCR and the genes amplicon sizes
(F: forward primer, R: reverse primer, bp: base pair)
Gene
Runx2

Sequences

Amplicon size

F: 5'-GATGGGACTGTGGTTACTGTCA-3'

110 bp

R: 5'-CTCAGATCGTTGAACCTTGC-3'
Collagen1

F: 5'-CAAGAACCCCAAGGACAAGAG-3'

169 bp

R: 5'-CTTGCAGTGGTACCTGATGTTC-3'
Osteocalcin

F: 5'-CTCACACTCCTCGCCCTATTG-3'

142 bp

R: 5'-GCCTGGGTCTCTTCACTACCT-3'
Cobra1

F: 5'-ACATCACCAAGCAGAGGAA-3'

366 bp

R: 5'-GATCCAGCTGTTCCAGCTTC-3'
Beta-actin

F: 5'-GCAAAGACCTGTACGCCAAC-3'

777 bp

R: 5'-GAGACCAAAAGCCTTCATACATCTC-3'

Table (2): Locations of the primers in respect to the exons
Primers

Location in respect to exons

Runx2

Primers are located on two different exons, exon 1 and exon 6.

Collagen1

Primers are located on two different exons, exon 1 and exon 51

Osteocalcin

Primers are located on two different exons, exon 1 and exon 4

Cobra1

Primers are located on two different exons, exon 1 and exon 13.

Beta-actin

Primers are located on one exon, as the gene contains one exon only.

Table (3): PCR conditions for each gene
Gene

Denaturation

Annealing

Number of

Elongation

cycles
Runx2

95°/10 min

95°/10 sec, 60°/20 sec, 72°/20 sec

40

72°/7 min

Collagen1

95°/2 min

95°/5 sec, 56°/20 sec, 72°/20 sec

40

72°/7 min

Osteocalcin

95°/2 min

95°/30 sec, 60°/30 sec, 72°/30 sec

40

72°/7 min

Cobra1

95°/5 min

95°/10 sec, 59.5°/20 sec, 72°/20 sec

23

72°/7 min

Beta-actin

95°/5 min

95°/10 sec, 58°/20 sec, 72°/20 sec

28

72°/7 min

21

Chapter (3): Results
3-1 L929 cells grown in osteogenic differentiation media exhibit osteoblast-like
phenotype within one week of culture:
The morphology of the studied cells has been examined microscopically at regular
periods. As previously reported, the L929 cells that were cultured in growth media
that did not contain osteogenic differentiation substances (control cells) exhibited
heterogeneous morphology, including mainly spindle-like, some epithelial-like, and
few round shaped cells during the whole period of the study (21 days). There was a
noticed increase in the number of round shaped cells as the confluency of cells
increased by time (Figure-1).
The cells that were grown in the osteogenic differentiation media developed
morphological changes that became apparent after 84 hours from the beginning of
culturing with the differentiation media. Cells assumed a triangular to cuboidal shape
(Figure-2). By the end of the incubation period (21 days), the vast majority of cells
exhibited the cuboidal shape.

(A) 10x magnification

(B) 10x magnification
Figure-1: L929 fibroblasts in normal growth media (A) at day 1 of the experiment (B) at day 21 of the
experiment. (10x magnification)
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(A) 20x magnification

(B) 20x magnification

(C) 10x magnication

(D) 10x magnification
Figure-2: L929 fibroblasts grown under differentiation osteogenic media (A) after 84 hours, (B) after 1
week, (C) after 2 weeks and (D) after3 weeks. (A and B: 20x magnification, C and D: 10x magnification).
Arrows are pointing deposits around cells.
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3-2 L929 cells cultured in osteogenic differentiation media produced calcium
deposits as indicated by Alizarin red S staining:
After two weeks from the start of the experiment, L929 fibroblasts were stained with
Alizarin red S staining to monitor calcium deposition in osteoblasts. The control cells
were slightly reddish, while cells that were cultured in differentiation osteogenic
media were stained darkly with the bright red color indicating the presence of calcium
deposits (Figure-3). After three weeks, almost no staining was observed in control
cells, while cells in differentiation media were stained darkly with the bright red color
(Figure-3).
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(A) 10x magnification

(B) 10x magnification

(C) 10x magnification

(D) 10x magnification
Figure-3: Alizarin red S staining after 2 weeks and from the beginning of the experiment: (A) fibroblasts
L929 in normal growth media, (B) fibroblasts L929 grown in differentiation osteogenic media, and after 3
weeks: (C) fibroblasts L929 in normal growth media, (D) fibroblasts L929 grown in differentiation
osteogenic media. (10x magnification)
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3-3 L929 cells cultured in osteogenic differentiation media demonstrated
osteoblast-like features as indicated by the expression of osteogenic factors
(Runx2, Collagen1, and Osteocalcin) at the RNA level:
The mRNA level of the genes was examined using reverse transcription PCR for
RNA extracted from the L929 cells that were cultured in regular media and those that
were induced to differentiate into osteoblasts at different intervals (day1, after two
weeks and after three weeks from the beginning of the experiment). Two negative
control reactions, one containing no reverse transcriptase and the second containing
no template were included in each reaction.
3-3-1 Levels of Beta-actin (house keeping gene) mRNA expression under
different media at different periods of times: (to be used for examining PCR
reaction validity).
Beta-actin gene expression was prominent in all the positive RT samples either for the
cells which were grown in regular non-osteogenic media at all-time intervals (day1,
day14, and day21) and for cells grown under differentiation osteogenic media at two
distinct time intervals (day14 and day21). Figure-4 accounts for the PCR analysis for
Beta-actin gene expression.
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Figure-4: Osteogenic factors were detected in L929 induced cells. A) PCR analysis for transcription
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of Beta-actin, Runx2, Collagen and Osteocalcin respectively from top to bottom.
B-actin: The transcription was abundant in all lanes containing reverse transcriptase enzyme in cells
cultured in regular or differentiation media at all-time intervals. The size of the bands is 777 bp, which is
indicative for Beta-actin gene.
Runx2: Thick bands in lanes of cells grown under differentiation osteogenic media, band after 21 days
is denser than that of bands after 14 days. Faint band appears in lane representing cells in normal
media at day 1. The size of the bands is 110 bp indicative for Runx2 gene.
Collagen1: Abundant bands representing Collagen1 gene presence in lanes of cells grown under
differentiation osteogenic media after 14 days and 21 days. The 14 days band is denser than that of 21
days. The size of bands is 169 bp that is indicative for Collagen1.
Osteocalcin: Dense band for cells grown in differentiation media at day 14, and a faint band for the
same cells under the same media at day 21. A band for Osteocalcin is present also in lane of negative
RT samples at day 21, which may indicate DNA contamination of this sample. The size of the band is
142 bp, which is indicative for Osteocalcin gene
B) Graphical representation for the transcription levels of Runx2, Collagen1 and Osteocalcin by ImageJ,
normalized to Beta-actin. Error bars and P-value for significance are represented. The Runx2
expression is significant in differentiated cells compared to the control cells after 14 and 21 days (***P <
0.001). The expression of differentiated cells after 21 days is significant compared to that after 14 days
(*P < 0.05).
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3-3-2 Levels of Runx2 mRNA expression under different media at different
periods:
The Runx2 expression was abundant in the cells grew in differentiation osteogenic
media. This is presented by dark bands in their lanes; however, the bands of the cells
after 21 days are thicker and more abundant than the product of cells after 14 days. A
faint band (PCR product) was detected in reactions missing the RT enzyme at day 14
and 21. Given that the Runx2 primers lie on different exons, the presence of a PCR
product at the expected size of amplification of mRNA in the negative reaction cannot
be attributed to DNA contamination. Most likely there was cross contamination
between PCR samples in the same run. In agreement with previous reports, a faint
band of Runx2 also appears in the lane representing cells grown in normal media at
day 1 which indicate a low level of Runx2 transcription. Figure-4A and -4B shows the
PCR expression analysis of Runx2 gene.
3-3-3 Levels of Collagen1 mRNA expression under different media at different
periods of times:
Dense bands were detected in lanes representing PCR Collagen1 levels in cells grown
in differentiation osteogenic media. The bands representing cells after 14 days are
thicker than those produced by cells after 21 days. This may indicate that Collagen1
expression is decreased with time during the periods of increased mineralization.
Figure-4 accounts for the PCR analysis for Collagen1 gene.
3-3-4 Levels of Osteocalcin mRNA expression under different media at different
periods of times:
The dense abundant band was present in the lane representing cells grown in
differentiation osteogenic media after 14 days from the start of the experiment
indicating that Osteocalcin transcription was prominent at that time. The less
prominent band was present in the lane representing cells under differentiation media
after 21 days from the start of the experiment, indicating that the transcription of
Osteocalcin decreased during the period between two and three weeks but still was
transcribed at the end of the third week. A band for Osteocalcin was present also in
the lane representing samples taken from cells cultured differentiation osteogenic
media after 21days, but the reverse transcriptase enzyme was not used in this sample
during cDNA synthesis, so this band may be due to DNA contamination of the
sample. Figure-4 accounts for the PCR analysis for Osteocalcin gene expression.
3-4 L929 cells cultured in osteogenic differentiation media display almost
complete downregulation of Cobra1 expression:
Transcription of Cobra1 gene appears in the PCR analysis in the three lanes
representing cells which were cultured in regular media that did not contain any
osteogenic differentiation factors at all three-time points (day1, day14 and day21). No
expression of Cobra1 has been produced by cells cultured in osteogenic
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differentiation media, indicating that Cobra1 expression has been shut down during
and after differentiation of osteoblasts at least between days 14 and day 21 from the
beginning of the differentiation.
Figure (5) accounts for the PCR analysis for expression of Cobra1 gene.
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Figure-5: PCR reaction for gene expressions of Cobra1, Cobra1 mRNA is detected in the un-induced
but not the induced L929 cells. A) Cobra1 expression in the cells grown in normal non differentiating
media at day1, day14 and day21. The intensity of the bands increased with time until day 21. The size
of the bands is 366 bp, that is indicative for Cobra1 gene.
B) Graphical representation for the transcription levels of Cobra1 by ImageJ, normalized to Beta-actin.
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Chapter (4) Discussion:
Somatic fully differentiated cells could successfully convert to another type of mature
somatic cells without the need to dedifferentiate the cells to obtain pluripotency
before induction of differentiation to another cell type. This was apparent from the
results of this research and previous findings as will be highlighted in the following
sections.
It has been reported that the pluripotent stem cells retain their potency by maintaining
the transcription of the main pluripotency genes such as Oct4, Sox2 and Nanog, and
sustaining the suppression of the transcription of genes responsible for differentiation
of pluripotent cells. Amleh and colleagues (Amleh et al., 2009) have demonstrated
the involvement of COBRA1, which is an integral member of the NELF complex, in
maintaining the pluripotency of mouse embryonic stem cells
In the current study, we induced the osteogenic differentiation of L929 using media
containing a cocktail of Dexamethazone, Ascorbic acid and Beta-Glycerol phosphate
and investigated the involvement of Cobra1 in the plasticity/potency of L929 cells. In
a previous study, the observation of cellular changes after induction of differentiation
was slower compared to the changes observed in the current study which will be
detailed in the following sections; this may be due to increasing the concentration of
Dexamethazone in the osteogenic differentiation media in the present study compared
to the previous one (Kasem, Tanom, 2011).
4-1 Morphological changes:
The observation of cells in differentiation media after three and a half days from the
onset of differentiation has shown apparent morphologic changes of those cells; the
cells assumed triangular to cuboidal shapes (Florian et al., 2009) and contained
prominent nuclei. These changes have continued as the observations after 1 week, 2
weeks and3 weeks show. Areas of extracellular deposits could be seen around some
cells after 1 week from differentiation, and these areas have increased by time to be
more abundant after 2 and 3 weeks.
On the other hand, un-induced L929 cells maintained mostly the spindle-like shape at
early time points and exhibited a noticeable increase in the round shaped cells with
increasing time (Michael et al., 2015).
4-2 Staining of calcium deposits
In agreement with previously reported data, mineralized osteoblasts derived from
L929 exhibit enhanced extracellular calcium deposits in response to an increased time
of induction as depicted by bright red Alizarin red S staining (Ji Eun et al., 2016).
However, in the current study, these changes were detected at an earlier time point
than previously reported (Kasem and Tanom., 2011).
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4-3 Effect of osteogenic media on transcription of Runx2:
There were no Runx2 RNA detected in cells which were grown in regular media
neither at day 14 or day 21. However, there was a faint band in the lane representing
cells cultured in standard media at day 1 which may indicate a low level of Runx2
transcription in fibroblasts (Masafumi et al., 2016). This discrepancy in Runx2 gene
expression levels could be due to the apparent overcrowding at days 14 and 21 or due
to spontaneous formation of germline-like cells. It has been reported by (Ma et al.,
2012) that L929 cells undergo spontaneous differentiation into germline-like cells
within 7 days in regular culture medium. Runx2 being the regulator for osteogenic
differentiation (Aaron., 2013) is transcribed in cells that were culture in osteogenic
differentiation media whether at day 14 or day 21 as indicated by the PCR analysis. It
is noted that Runx2 PCR product increased by time from 2 to 3 weeks, which may
suggest the maturation of the differentiated cells into functional osteoblasts. These
findings indicate the positive effect of the osteogenic differentiation molecules on the
conversion of fibroblasts to osteoblasts.
4-4 Effect of osteogenic media on transcription of Collagen1:
In agreement with previous findings (Chan et al., 1991), (Gallivan et al., 1997).we
have not detected Collagen1 gene transcripts in cells cultured in the regular medium
throughout the experiment period, whereas the induced L929 cells express Collagen1
transcripts at days 14 and 21. The density of the band representing Collagen1
transcription shows increased transcription at day 14 than that at day 21. This may
indicate that the Collagen1 is required during early differentiation stages more than at
the time when the mineralization machinery dominates.
4-5 Effect of osteogenic media on transcription of Osteocalcin:
Our results emphasize what has been already reported that Osteocalcin gene is
required for osteogenic differentiation, thus expressed in osteoblasts (Lee NK et al.,
2007) and is considered as a marker for osteoblasts detection. Here again, like the
case with Collagen1, the transcription level of Osteocalcin is more prominent at day
14 than day 21 from the start of the experiment. However, it was noted that the
difference in transcription pattern between day 14 and 21 is more evident in the case
of Osteocalcin, where a thick band was present at day 14 while a relatively weak one
was present at day 21. This may indicate that the role of Osteocalcin precedes the
mineralization of osteoblastic matrix.
4-6 Effect of osteogenic media on transcription of Cobra1:
The transcription of Cobra1 was apparent in the PCR reactions for cells grown in
regular media at all times of the observation but not found in cells cultured in
osteogenic differentiation media neither at day 14 or day 21. This may suggest a
suppressive effect of the osteogenic media on the transcription of Cobra1.
Alternatively, this may indicate that COBRA1, as an integral member of the NELF
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complex, is required to maintain the plasticity of L929 and that for osteogenic
differentiation to occur Cobra1 levels are dampened. We do not know exactly how
this happens, does the osteogenic molecules directly suppress the transcription of
Cobra1? Or is the activated differentiation machinery induced by the osteogenic
media involved in the downregulation of Cobra1? Further studies are needed to test
the exact mechanism by which the transcription of Cobra1 is suppressed.
4-7 Analysis of the transcription pattern of Beta-actin:
Beta-actin is considered as one of the house keeping genes which are transcribed
normally and consistently in all living cells, and it was used in this experiment as a
control for all reactions to test the validity of PCR reactions, to ensure the PCR
reactions results for rest of products.
The Beta-actin was transcribed as expected in all reactions that include RNA and
reverse transcriptase enzyme (+v RT) indicating that results obtained from the other
PCR reactions are reliable.
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Chapter (5): Conclusion
According to our findings, we can conclude that the use of osteogenic substances has
successfully induced the mouse fibroblasts L929 to differentiate into mature and
active osteoblasts.
It should be noted that in the present study the Dexamethazone used in the osteogenic
differentiation media was of different concentration than previously recommended in
the literature. This difference may have contributed to the early differentiation
induction.
We also can conclude that the Collagen1 and Osteocalcin secretion has not increased
with time and their level is less during the mineralization phase of osteoblasts.
Interestingly, the Cobra1 expression was abolished on day 14 of induction. While the
use of osteogenic differentiation media may have a suppressive effect on the Cobra1
transcription, it appears that the presence of Cobra1 transcription in the fibroblasts did
not suppress the fibroblastic capacity to differentiate into osteoblasts. It is likely that
COBRA1 is required to support the plasticity of L929 cells similar to the role it plays
in maintaining the pluripotent state of the mouse embryonic stem cells.
This work may be considered as a foundation to understand the inhibitory effect of the
differentiation media and conditions on COBRA1 transcription.
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Future Recommendations
In this research, the timing for alizarin red S staining for calcium deposits and for
RNA extraction from samples cultured in differentiation media (day 14 and day 21)
were based on previous similar research strategies. In those studies-, the
mineralization was proven not to occur before day 21 (Kasem, Tanom, 2011).
Interestingly, in the current research, we observed that the morphological changes and
the mineralization detection using the stain have occurred at earlier times than the
previously reported. Therefore, we recommend monitoring the expression of
osteogenic markers including the process of mineralization at an earlier stage; i.e.,
within a week of the onset of induction and to try different concentrations of
Dexamethazone including the previously used one.
The analysis of Cobra1 transcription was also too late. To better understand the role
of COBRA1 in the maintenance of the L929 plasticity, the expression levels of
Cobra1 need to be examined within a few days of induction.
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